Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Hande Bio-Engineering is a specialized biotechnology company headquartered in Xi'an, China, focused on the research, development, and industrial-scale production of natural plant extracts and pharmaceutical intermediates. The company is a globally recognized leader in the production of taxane-based active pharmaceutical ingredients (APIs), including Paclitaxel, Docetaxel, and Cabazitaxel. Utilizing advanced extraction and semi-synthesis technologies, Hande Bio-Engineering supplies high-purity compounds to major pharmaceutical manufacturers worldwide for use in oncology treatments. Their facilities are GMP-certified, ensuring compliance with international quality standards for pharmaceutical production. The company's strategic focus on the taxane family has made it a critical link in the global supply chain for essential chemotherapy medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Hande Bioengineering.